Temasek Holdings
SQZ

Temasek Holdings’s SQZ Biotechnologies Company SQZ Stock Holding History

Temasek Holdings’s Portfolio SQZ Stock Details SQZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-2,758,169
Closed -$745K – 95
2023
Q2 		$745K Hold
2,758,169
– – ﹤0.01% 73
2023
Q1 		$1.54M Hold
2,758,169
– – 0.01% 63
2022
Q4 		$2.04M Hold
2,758,169
– – 0.01% 64
2022
Q3 		$6.29M Hold
2,758,169
– – 0.04% 64
2022
Q2 		$8.77M Hold
2,758,169
– – 0.05% 72
2022
Q1 		$13.3M Hold
2,758,169
– – 0.06% 77
2021
Q4 		$24.6M Hold
2,758,169
– – 0.09% 66
2021
Q3 		$39.8M Buy
2,758,169
+223,993
+9% +$3.04M 0.14% 60
2021
Q2 		$36.6M Buy
2,534,176
+20,252
+0.8% +$265K 0.12% 59
2021
Q1 		$34.4M Hold
2,513,924
– – 0.13% 50
2020
Q4 		$72.9M Buy
+2,513,924
New +$64.2M 0.31% 41

Other funds holding SQZ

AIG
American International Group New York $609M AUM 23.67% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
BSB
Bangor Savings Bank Bangor, Maine $1.36B AUM 19.29% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Temasek Holdings's SQZ Position: Q3 2023 in Review

Temasek Holdings sold out of SQZ Biotechnologies Company (SQZ) in Q3 2023, closing a stake of 2,758,169 shares — an estimated $745K sold.

Temasek Holdings first reported a position in SQZ in Q4 2020 and held it in 11 quarters. The position peaked at $72.9M in Q4 2020. 5 funds tracked by Wall St. Rank hold SQZ as of Q3 2023.

  • Temasek Holdings reported no remaining SQZ Biotechnologies Company position as of Q3 2023 after selling out during the quarter.
  • Temasek Holdings sold 2,758,169 SQZ Biotechnologies Company shares in Q3 2023, an estimated $745K.
  • Temasek Holdings first reported a position in SQZ Biotechnologies Company in Q4 2020 and held it in 11 quarters.
  • Temasek Holdings's SQZ Biotechnologies Company position peaked at $72.9M in Q4 2020.
  • 5 funds tracked by Wall St. Rank held SQZ Biotechnologies Company as of Q3 2023.

Based on Temasek Holdings's 13F filing for Q3 2023, filed 14 Nov 2023.